Capital Markets Trading (UK)’s AbbVie ABBV Stock Holding History

Capital Markets Trading (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-33,624	Closed	-$3.97M	–	189
2021 Q3	$3.66M	Buy	33,624 +12,520	+59%	+$1.43M	0.05%	129
2021 Q2	$2.38M	Buy	21,104 +754	+4%	+$84.9K	0.04%	136
2021 Q1	$2.2M	Buy	20,350 +8,209	+68%	+$878K	0.04%	138
2020 Q4	$1.3M	Sell	12,141 -2,795	-19%	-$269K	0.02%	155
2020 Q3	$1.26M	Sell	14,936 -19,626	-57%	-$1.85M	0.02%	152
2020 Q2	$3.39M	Buy	34,562 +12,297	+55%	+$1.08M	0.09%	113
2020 Q1	$1.7M	Buy	22,265 +12,566	+130%	+$1.07M	0.04%	145
2019 Q4	$859K	Buy	9,699 +2,685	+38%	+$223K	0.03%	147
2019 Q3	$531K	Sell	7,014 -11,004	-61%	-$754K	0.02%	178
2019 Q2	$1.31M	Buy	18,018 +10,189	+130%	+$801K	0.06%	150
2019 Q1	$631K	Buy	+7,829	New	+$640K	0.04%	144
2018 Q4	–	Sell	-17,317	Closed	-$1.52M	–	184
2018 Q3	$1.64M	Buy	+17,317	New	+$1.64M	0.08%	142
2018 Q2	–	Sell	-4,405	Closed	-$430K	–	180
2018 Q1	$417K	Buy	+4,405	New	+$484K	0.02%	157

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Markets Trading (UK)'s ABBV Position: Q4 2021 in Review

Capital Markets Trading (UK) sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 33,624 shares — an estimated $3.97M sold.

Capital Markets Trading (UK) first reported a position in ABBV in Q1 2018 and held it in 13 quarters. The position peaked at $3.66M in Q3 2021. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Capital Markets Trading (UK) reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Capital Markets Trading (UK) sold 33,624 AbbVie shares in Q4 2021, an estimated $3.97M.
Capital Markets Trading (UK) first reported a position in AbbVie in Q1 2018 and held it in 13 quarters.
Capital Markets Trading (UK)'s AbbVie position peaked at $3.66M in Q3 2021.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Capital Markets Trading (UK)'s 13F filing for Q4 2021, filed 15 Feb 2022.